Z79.81 – Long term (current) use of agents affecting estrogen receptors and estrogen levels
Coding Notes
Active
Non-billable / Non-specific, not valid for HIPAA-covered transactions
Code First
, if applicable:
malignant neoplasm of breast (C50.-)
malignant neoplasm of prostate (C61)
Additional
code, if applicable, to identify:
estrogen receptor positive status (Z17.0)
family history of breast cancer (Z80.3)
genetic susceptibility to malignant neoplasm (cancer) (Z15.0-)
personal history of breast cancer (Z85.3)
personal history of prostate cancer (Z85.46)
postmenopausal status (Z78.0)
Type 1 Excludes
hormone replacement therapy (Z79.890)
Child Codes
Sibling Codes
Parent Sibling Codes
View in Tabular
| Code | Title |
|---|---|
| Z00-Z99 | Factors influencing health status and contact with health services (Z00-Z99) |
| Z77-Z99 | Persons with potential health hazards related to family and personal history and certain conditions influencing health status (Z77-Z99) |
| Z79 | Long term (current) drug therapy |
| Z79.8 | Other long term (current) drug therapy |
| Z79.81 |
Long term (current) use of agents affecting estrogen receptors and estrogen levels
Use Additional
code, if applicable, to identify:
estrogen receptor positive status (Z17.0)
family history of breast cancer (Z80.3)
genetic susceptibility to malignant neoplasm (cancer) (Z15.0-)
personal history of breast cancer (Z85.3)
personal history of prostate cancer (Z85.46)
postmenopausal status (Z78.0)
Type 1 Excludes
hormone replacement therapy (Z79.890)
Code First
, if applicable:
malignant neoplasm of breast (C50.-)
malignant neoplasm of prostate (C61)
|
| Z79.810 | Long term (current) use of selective estrogen receptor modulators (SERMs) |
| Z79.811 | Long term (current) use of aromatase inhibitors |
| Z79.818 | Long term (current) use of other agents affecting estrogen receptors and estrogen levels |